Efficacy and safety of apatinib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib: An open-label, multicenter, single-arm, phase II trial

被引：0
|
作者：
Cai, Z. [1 ]
Zhang, B. [1 ]
Yin, Y. [1 ]
Cao, D. [2 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Ctr Canc, Dept Abdominal Oncol, Chengdu, Sichuan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1702P
引用
收藏
页码：698 / 698
页数：1
相关论文
共 50 条
  • [41] Phase II Open-Label, Single-Arm Trial to Investigate the Efficacy and Safety of Topical Remetinostat Gel in Patients with Basal Cell Carcinoma
    Kilgour, James M.
    Shah, Aatman
    Urman, Nicole M.
    Eichstadt, Shaundra
    Do, Hanh N.
    Bailey, Irene
    Mirza, Amar
    Li, Shufeng
    Oro, Anthony E.
    Aasi, Sumaira Z.
    Sarin, Kavita Y.
    CLINICAL CANCER RESEARCH, 2021, 27 (17) : 4717 - 4725
  • [42] INTRIGUE: A phase III, randomized,open-label study to evaluate the efficacy and safety of ripretinib versus sunitinib in patients with advanced gastrointestinal stromal tumor previously treated with imatinib
    Heinrich, Michael C.
    Jones, Robin Lewis
    Gelderblom, Hans
    George, Suzanne
    Schoffski, Patrick
    von Mehren, Margaret
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (36)
  • [43] Evaluating the Efficacy and Safety of Silodosin on Nocturia in Patients With Benign Prostatic Hyperplasia: A Multicenter, Prospective, Open-label, Single-arm, Phase IV Trial
    Cho, Kang Jun
    Lee, Jeong Zoo
    Song, Yun Seob
    Choi, Jong Bo
    Kim, Dae Kyung
    Kim, Yong Tae
    Kim, Joon Chul
    UROLOGY, 2018, 121 : 153 - 157
  • [44] Efficacy and safety of sintilimab plus XELOX as neoadjuvant therapy in patients with locally advanced gastric cancer: A single-arm open-label phase II trial.
    Guo, Honghai
    Ding, Ping'an
    Yang, Peigang
    Tian, Yuan
    Liu, Yang
    Zhang, Ze
    Zheng, Tao
    Zhang, Zhidong
    Wang, Dong
    Tan, Bibo
    Zhao, Xuefeng
    Li, Yong
    Zhao, Qun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16091 - E16091
  • [45] Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
    Tsuyoshi Matsumura
    Hiroya Hashimoto
    Masahiro Sekimizu
    Akiko M. Saito
    Yasufumi Motoyoshi
    Akinori Nakamura
    Satoshi Kuru
    Takayasu Fukudome
    Kazuhiko Segawa
    Toshiaki Takahashi
    Takuhisa Tamura
    Tetsuo Komori
    Chigusa Watanabe
    Masanori Asakura
    Koichi Kimura
    Yuko Iwata
    Orphanet Journal of Rare Diseases, 17
  • [46] Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
    Matsumura, Tsuyoshi
    Hashimoto, Hiroya
    Sekimizu, Masahiro
    Saito, Akiko M.
    Motoyoshi, Yasufumi
    Nakamura, Akinori
    Kuru, Satoshi
    Fukudome, Takayasu
    Segawa, Kazuhiko
    Takahashi, Toshiaki
    Tamura, Takuhisa
    Komori, Tetsuo
    Watanabe, Chigusa
    Asakura, Masanori
    Kimura, Koichi
    Iwata, Yuko
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [47] A single-arm, open-label, multicenter study of tranilast for advanced heart failure in patients with muscular dystrophy
    Matsumura, T.
    Hashimoto, H.
    Sekimizu, M.
    Saito, A.
    Asakura, M.
    Kimura, K.
    Iwata, Y.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S103 - S103
  • [48] Clinical Efficacy and Safety of Nivolumab: Results of a Multicenter, Open-label, Single-arm, Japanese Phase II study in Malignant Pleural Mesothelioma (MERIT)
    Okada, Morihito
    Kijima, Takashi
    Aoe, Keisuke
    Kato, Terufumi
    Fujimoto, Nobukazu
    Nakagawa, Kazuhiko
    Takeda, Yuichiro
    Hida, Toyoaki
    Kanai, Kuninobu
    Imamura, Fumio
    Oizumi, Satoshi
    Takahashi, Toshiaki
    Takenoyama, Mitsuhiro
    Tanaka, Hiroshi
    Hirano, Jun
    Namba, Yoshinobu
    Ohe, Yuichiro
    CLINICAL CANCER RESEARCH, 2019, 25 (18) : 5485 - 5492
  • [49] Surufatinib in combination with toripalimab in patients with advanced neuroendocrine carcinoma: Results from a multicenter, open-label, single-arm, phase II trial.
    Shen, Lin
    Yu, Xianjun
    Lu, Ming
    Zhang, Xing
    Cheng, Ying
    Zhang, Yanqiao
    Li, Zhiping
    Xu, Jianming
    Weng, Desheng
    Wu, Chunjiao
    Ma, Yue
    Cheng, Ke
    Wang, Wenquan
    Gao, Heli
    Li, Yi
    Zhou, Jinghong
    Shi, Haiyan
    Tan, Panfeng
    Su, Weiguo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [50] Pazopanib in advanced germ cell tumors after chemotherapy failure: results of the open-label, single-arm, phase 2 Pazotest trial
    Necchi, A.
    Lo Vullo, S.
    Giannatempo, P.
    Raggi, D.
    Calareso, G.
    Togliardi, E.
    Crippa, F.
    Pennati, M.
    Zaffaroni, N.
    Perrone, F.
    Busico, A.
    Colecchia, M.
    Nicolai, N.
    Mariani, L.
    Salvioni, R.
    ANNALS OF ONCOLOGY, 2017, 28 (06) : 1346 - 1351
12345